Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial
SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer
NCI Begins Ovarian Cancer Trial To Build Blood Samples
Aromasin Approved By FDA For ER+ Early Breast Cancer
NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk
HRT Doesn’t Raise Cancer Risk Following Oophorectomy
Obesity, Faster Weight Gain, Linked To Poor Prognosis
Study Finds Up To 12 Percent Of Specimens Misdiagnosed
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









